תבנית:תרופה/סולו מדרול 500 מ"ג - Solu medrol 500 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | |
| ×ר××× ×¤×¢×× (ATC5) | Methylprednisolone AS SODIUM SUCCINATE 62.5MG/ML âH02AB04 |
| צ×רת ××ª× | I.M; I.V |
| צ×רת ××× ×× | POWDER FOR SOLUTION FOR INJ/INF |
| ×ת×××× | Solu Medrol is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation.
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/ס××× ××ר×× 500 ×"× - Solu medrol 500 mg | |
| ×ת××ת ××× ×× | Posology and method of administration |
| ×ת××××ת × ×× | Contraindications |
| ת×פע×ת ××××× | Undesirable effects |
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction |
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation |
| פר×ק×××× ×××§× | Pharmacodynamic Properties |
| פר×ק×ק×× ×××§× | Pharmacokinetic Properties |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× | |
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ס××× ××ר×× 500 ×"× Â® ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | PFIZER MANUFACTURING BELGIUM NV/SA |
| ×©× ××¢× ×ר×ש×× | PFIZER PFE PHARMACEUTICALS ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 01/1983. ר×ש××× ×ת×ר××: 05/2014 |
| ת×ר×× ×¢×××× ××ר×× | 25/04/17 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ס××× ××ר×× 500 ×"× - Solu medrol 500 mg
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/ס××× ××ר×× 500 ×"× - Solu medrol 500 mg}}
×:
{{תר×פ×/ס××× ××ר×× 500 ×"× - Solu medrol 500 mg
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־25 באפריל 2017 ב־19:22